approval · primary record
ROSUVASTATIN CALCIUM
FDA · NDA · 2025-02-12
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-02-12 |
| Brand | EZALLOR SPRINKLE |
| Sponsor | SUN PHARM |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:42.252Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ROSUVASTATIN CALCIUM:2025-02-12
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Rosuvastatin Calcium · compound